Concepedia

Camlin Tierney

CT

Statistics

Publications

44

Citations

3.3K

H-Index

24

Active since

1994

Affiliations

Harvard University(Current)

Cancer Research And Biostatistics

Brigham and Women's Hospital

Harbor–UCLA Medical Center

The Lundquist Institute

Camlin Tierney is an author at Harvard University specializing in medicine, hiv, and pharmacotherapy.

Top concepts

Publications per year

1994–2023

44

Publications

44

Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study.

David W. Haas, Heather J. Ribaudo, Richard B. Kim et al. · PubMed · 2004 · 628 citations

Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202

Grace A. McComsey, Douglas Kitch, Eric S. Daar et al. · The Journal of Infectious Diseases · 2011 · 495 citations · Full text

Abacavir–Lamivudine versus Tenofovir–Emtricitabine for Initial HIV-1 Therapy

Paul E. Sax, Camlin Tierney, Ann C. Collier et al. · New England Journal of Medicine · 2009 · 313 citations · Full text

Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B

Gonzague Jourdain, Nicole Ngo‐Giang‐Huong, Linda Harrison et al. · New England Journal of Medicine · 2018 · 274 citations

Association Between Efavirenz as Initial Therapy for HIV-1 Infection and Increased Risk for Suicidal Ideation or Attempted or Completed Suicide

Katie R. Mollan, Marlene Smurzynski, Joseph J. Eron et al. · Annals of Internal Medicine · 2014 · 207 citations · Full text

1–5 of 44